Article

Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate Cancer

B. Joyce Davison

John Oliffe

Tom Pickles

Lawrence Mroz

prostate cancer, prostate specific antigen
ONF 2009, 36(1), 89-96. DOI: 10.1188/09.ONF.89-96

Purpose/Objectives: To identify and describe decision-making influences on men who decide to manage their low-risk prostate cancer with active surveillance.

Research Approach: Qualitative, semistructured interview.

Setting: The Prostate Centre at Vancouver General Hospital in Canada.

Participants: 25 patients diagnosed with low-risk prostate cancer and on active surveillance.

Methodologic Approach: An interpretative, descriptive, qualitative design.

Main Research Variables: Factors that influenced men's decisions to take up active surveillance.

Findings: The specialists' description of the prostate cancer was the most influential factor on men choosing active surveillance. Patients did not consider their prostate cancer to be life threatening and, in general, were relieved that no treatment was required. Avoiding treatment-related suffering and physical dysfunction and side effects such as impotence and incontinence was cited as the major reason to delay treatment. Few men actively sought treatment or health-promotion information following their treatment decision. Female partners played a supportive role in the decision. The need for active treatment if the cancer progressed was acknowledged. Patients were hopeful that new treatments would be available when and if they needed them. Being older and having comorbidities did not preclude the desire for future active treatment. Patients carried on with their lives as usual and did not report having any major distress related to being on active surveillance.

Conclusions: The study findings indicate that men are strongly influenced by the treating specialist in taking up active surveillance and planning future active treatments. As such, most men relied on their specialists' recommendation and did not perceive the need for any adjunct therapy or support until the cancer required active treatment.

Interpretation: Oncology nurses should work collaborative-ly with specialists to ensure that men receive the information they need to make informed treatment decisions.

Jump to a section

    References

    Altwein, J., Ekman, P., Barry, M., Biermann, C., Carlsson, P., Fossa, S., et al. (1997). How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology, 49(4A, Suppl.), 66-76.
    Arredondo, S. A., Downs, T. M., Lubeck, D. P., Pasta, D. J., Silva, S. J., Wallace, K. L., et al. (2004). Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE. Journal of Urology, 172(5, Pt. 1), 1830-1834.
    Bailey, D. E., Jr., Wallace, M., & Mishel, M. H. (2007). Watching, waiting and uncertainty in prostate cancer. Journal of Clinical Nursing, 16(4), 734-741.
    Barocas, D. A., Cowan, J. E., Smith, J. A., & Carrol, P. R. (2008). What percentage of patients with newly-diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. Journal of Urology, 180(4), 1330-1335.
    Bill-Axelson, A., Holmberg, L., Ruutu, M., Haggman, M., Andersson, S. O., Bratell, S., et al. (2005). Radical prostatectomy versus watchful waiting in early prostate cancer. New England Journal of Medicine, 352(19), 1977-1984.
    Carter, H. B., Kettermann, A., Warlick, C., Metter, E. J., Landis, P., Walsh, P. C., et al. (2007). Expectant management of prostate cancer with curative intent: An update of the Johns Hopkins experience. Journal of Urology, 178(6), 2359-2364.
    Chapple, A., Ziebland, S., Herxheimer, A., McPherson, A., Shepperd, S., & Miller, R. (2002). Is "watchful waiting" a real choice for men with prostate cancer? A qualitative study. BJU International, 90(3), 257-264.
    Cooperberg, M. R., Lubeck, D. P., Meng, M. V., Mehta, S. S., & Carroll, P. R. (2004). The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management. Journal of Clinical Oncology, 22(11), 2141-2149.
    Davison, B. J., & Degner, L F. (1997). Empowerment of men newly diagnosed with prostate cancer. Cancer Nursing, 20(3), 187-196.
    Davison, B. J., Goldenberg, S. L., Wiens, K. P., & Cleave, M. E. (2007). Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nursing, 30, 1-9.
    Davison, B. J., Gleave, M. E., Goldenberg, S. L., Degner, L. F., Hoffart, D., & Berkowitz, J. (2002). Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nursing, 25(1), 42-49.
    Davison, B. J., Goldenberg, S. L., Gleave, M. E., & Degner, L. F., (2003). Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer. Oncology Nursing Forum, 30(1), 107-114.
    Demark-Wahnefried, W., Schildkraut, J. M., Iselin, C. E., Conlisk, E., Kavee, A., Aldrich, T. E., et al. (1998). Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer, 83(2), 320-330.
    Denberg, T. D., Melhado, T. V., & Steiner, J. F. (2006). Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote. Cancer, 107(3), 620-630.
    Glaser, B. G. (1978). Theoretical sensitivity: Advances in the methodology of grounded theory. Mill Valley, CA: Sociology Press.
    Hall, J. D., Boyd, J. C., Lippert, M. C., & Theodorescu, D. (2003). Why patients choose prostatectomy or brachytherapy for localized prostate cancer: Results of a descriptive survey. Urology, 61 (2), 402-407.
    Harlan, S. R., Cooperberg, M. R., Elkin, E. P., Lubeck, D. P., Meng, M. V., Mehta, S. S., et al. (2003). Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from CaPSURE. Journal of Urology, 170(5), 1804-1807.
    Holmboe, E. S., & Concato, J. (2000). Treatment decisions for localized prostate cancer: Asking men what's important. Journal of General Internal Medicine, 15(10), 694-701.
    Klotz, L. (2002). Expectant management with selective delayed intervention for favorable risk prostate cancer. Urologic Oncology, 7(5), 175-179.
    Klotz, L. (2006). Active surveillance with selective delayed intervention for favorable risk prostate cancer. Urologic Oncology, 24(1), 46-50.
    Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer.
    Litwin, M. S., Flanders, S. C., Pasta, D. J., Stoddard, M. L., Lubeck, D. P., & Henning, J. M. (1999). Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology, 54(3), 503-508.
    Litwin, M. S., Gore, J. L., Kwan, L., Brandeis, J. M., Lee, S. P., Withers, H. R., et al. (2007). Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer, 109(11), 2239-2247.
    Litwin, M. S., Sadetsky, N., Pasta, D. J., & Lubeck, D. P. (2004). Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE. Journal of Urology, 172(2), 515-519.
    McGregor, S. (2003a). Information on video format can help patients with localised prostate cancer to be partners in decision making. Patient Education and Counseling, 49(3), 279-283.
    McGregor, S. (2003b). What information patients with localised prostate cancer hear and understand. Patient Education and Counseling, 49(3), 273-278.
    Miles, B. J., Giesler, B., & Kattan, M. W. (1999). Recall and attitudes in patients with prostate cancer. Urology, 53(1), 169-174.
    National Cancer Institute of Canada. (2007). Canadian cancer statistics 2007. Toronto, Canada: Canadian Cancer Society.
    Oiler, C. (1982). The phenomenological approach in nursing research. Nursing Research, 31(3), 178-181.
    Parker, C. (2004). Active surveillance of early prostate cancer: Rationale, initial results and future developments. Prostate Cancer and Prostatic Diseases, 7(3), 184-187.
    Srirangam, S. J., Pearson, E., Grose, C., Brown, S. C., Collins, G. N., & O'Reilly, P. H. (2003). Partner's influence on patient preference for treatment in early prostate cancer. BJU International, 92(4), 365-369.
    Zakowski, S. G., Harris, C., Krueger, N., Laubmeier, K. K., Garrett, S., Flanigan, R., et al. (2003). Social barriers to emotional expression and their relations to distress in male and female cancer patients. British Journal of Health Psychology, 8(Pt. 3), 271-286.